Article Details
Retrieved on: 2022-11-08 19:02:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A Q&A with Dr. Bonaca highlights new data on rivaroxaban for PAD and the late-breaking science at AHA 2022. Advertisement. New Analyses ...
Article found on: www.hcplive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here